Your shopping cart is empty!
Clinical and Laboratory Standards Institute, 01/01/2008
Publisher: CLSI
File Format: PDF
$90.00$180.00
Published:01/01/2008
Pages:64
File Size:1 file , 1.5 MB
Note:This product is unavailable in Russia, Belarus
This document contains a protocol that optimizes the experimental design for the evaluation of qualitative tests, to better measure performance and provide a structured data analysis.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.
Microarrays for Diagnosis and Monitoring of Infectious Diseases; Approved Guideline, MM22AE
$90.00 $180.00
Nucleic Acid Sequencing Methods in Diagnostic Laboratory Medicine; Approved Guideline, MM09A2
Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard -Ninth Edition / Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement
$123.00 $247.42
Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard -Eleventh Edition/Performance Standards for Antimicrobial Susceptibility Testing, Twenty-Fourth Informational SUpplement
$115.00 $231.69
